本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

全球血液療法

68.49
0.0000
成交量:- -
成交額:2.25億
市值:46.21億
市盈率:-13.69
高:68.49
開:68.49
低:68.49
收:68.49
52周最高:73.02
52周最低:21.65
股本:6,747.62萬
流通股本:5,857.65萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-5.0019
每股收益(LYR):-4.8138
淨資產收益率:-148.56%
總資產收益率:-25.18%
市淨率:39.05
市盈率(LYR):-14.23

資料載入中...

2019/08/05

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/05

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/05

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/05

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/28

員工持股計劃

Securities to be offered to employees in employee benefit plans
2019/06/28

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2019/06/20

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/20

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/20

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/20

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/20

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/20

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/20

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/20

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/20

重要事件披露

Current report, item 5.07
2019/06/14

重要事件披露

Current report, item 8.01
2019/05/10

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/05/08

重要事件披露

Current report, items 2.02 and 9.01
2019/03/29

[修訂]季度報告

[Amend] Quarterly report [Sections 13 or 15(d)]
2016/10/25

SEC問詢函